Trophoblastic embolism in sudden maternal death

Area of Science:

• Pathology
• Immunohistochemistry
• Maternal Mortality

Background:

• Trophoblastic embolism (TE) is a rare but potentially fatal condition.
• Identifying the morphology and origin of trophoblasts in maternal autopsy is crucial for understanding causes of death.

Purpose of the Study:

• To investigate the presence and characteristics of trophoblastic embolism in maternal autopsy cases.
• To differentiate types of trophoblastic embolism based on trophoblast morphology.
• To determine the potential role of TE in sudden maternal death.

Main Methods:

• Maternal autopsy cases were analyzed for trophoblastic embolism.
• Immunocytochemical methods using antisera to placental antigen (PA) and human placental lactogen (HPL) were employed for trophoblast identification.
• Morphological analysis differentiated between whole trophoblastic cells (TE-Type I) and amorphous fragments (TE-Type II).

Main Results:

• Trophoblastic embolism was identified in three out of eight maternal autopsy cases.
• Immunocytochemistry effectively identified trophoblasts.
• Two distinct morphological types of TE were observed: TE-Type I (whole cells) and TE-Type II (amorphous fragments).
• TE-Type II was confirmed in the central nervous system, presenting as trophoblastic emboli in the brain.

Conclusions:

• Trophoblastic embolism is detectable in maternal autopsies using immunocytochemistry.
• Morphological differentiation of TE into two types is possible.
• Amorphous trophoblastic fragments (TE-Type II), particularly when found in the brain, are implicated as a cause of sudden maternal death.